3Thongkoom P, Kanjanahareutai S, Chantrakooptungool S, et al. Vancomycin resistant enteroeocci(VRE) isolates isolated in Rajavithi Hospital between 1999 and 2009 [J]. J Med Assoc Thailand, 2012,95 (S3) :S7-S15.
4Vieira A, Silva Y J, Cunha A. Phage therapy to control multi- drug resistant pseudomonas aeruginosa skin infections : in vitro and ex vivo experiments[J]. Eur J Clin Microb Infect Dis,2012,3(11) :3241-3249.
5Glukhov A S, Krutilina A I, Shlyapnikov M G, et al. Genomic analysis of pseudomonas putida phage tf with localized single- strand DNA interruptions[J]. PLoS One,2012,7(12) :e51163.
6Loc Carrillo C, Abedon S T. Pros and cons of phage therapy [J]. Bacteriophage,2011,1(2): 111-114.
7Sheng H, Knecht H J, Kudva I T, et al. Application of bacte- riophages to control intestinal Escherichia coli O157:H7 levels in ruminants[J]. Appl Environ Microbiol, 2006,72 (8) : 5359- 5366.
8Barrow P,Lovell M,Berchieri A Jr. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitishin chicken and calves[EB/OL]. Clin Vac Immu- nol, 1998,5 : 294-298.
9Glukhov A S, Krutilina A I,Shlyapnikov M G, et al. Genomic analysis of pseudomonas putida phage tf with localized single strand DNA interruptions [J]. PLoS One, 2012, 7 (12): e51163.
10Catherine L C,Abedon S T. Pros and cons of phage therapy [J]. Bacteriophage, 2011,1(2):111-114.
